相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice
Mengque Xu et al.
JOURNAL OF CROHNS & COLITIS (2021)
Microbial and metabolic features associated with outcome of infliximab therapy in pediatric Crohn's disease
Yizhong Wang et al.
GUT MICROBES (2021)
Integrative Analysis of Colonic Biopsies from Inflammatory Bowel Disease Patients Identifies an Interaction Between Microbial Bile Acid-inducible Gene Abundance and Human Angiopoietin-like 4 Gene Expression
Cristian Hernandez-Rocha et al.
JOURNAL OF CROHNS & COLITIS (2021)
Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis
Zhen-Huan Yang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis
Daniel van der Lelie et al.
NATURE COMMUNICATIONS (2021)
Unconjugated and secondary bile acid profiles in response to higher-fat, lower-carbohydrate diet and associated with related gut microbiota: A 6-month randomized controlled-feeding trial
Yi Wan et al.
CLINICAL NUTRITION (2020)
Risk of colorectal cancer in inflammatory bowel diseases
Muhammad Shahid Nadeem et al.
SEMINARS IN CANCER BIOLOGY (2020)
Innate lymphoid cells link gut microbes with mucosal T cell immunity
Jim G. Castellanos et al.
GUT MICROBES (2020)
Scientific frontiers in faecal microbiota transplantation: joint document of Asia-Pacific Association of Gastroenterology (APAGE) and Asia-Pacific Society for Digestive Endoscopy (APSDE)
Siew C. Ng et al.
GUT (2020)
Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Sidhartha R. Sinha et al.
CELL HOST & MICROBE (2020)
ESPEN practical guideline: Clinical Nutrition in inflammatory bowel disease
Stephan C. Bischoff et al.
CLINICAL NUTRITION (2020)
Fucose Ameliorate Intestinal Inflammation Through Modulating the Crosstalk Between Bile Acids and Gut Microbiota in a Chronic Colitis Murine Model
Jun Ke et al.
INFLAMMATORY BOWEL DISEASES (2020)
The relationship between fecal bile acids and microbiome community structure in pediatric Crohn's disease
Jessica Connors et al.
ISME JOURNAL (2020)
The microbiome and inflammatory bowel disease
Kerri L. Glassner et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
A Pilot Integrative Analysis of Colonic Gene Expression, Gut Microbiota, and Immune Infiltration in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Association of Disease With Bile Acid Pathways
Mohammed Nabil Quraishi et al.
JOURNAL OF CROHNS & COLITIS (2020)
Microbial bile acid metabolites modulate gut RORγ+ regulatory T cell homeostasis
Xinyang Song et al.
NATURE (2020)
The microbiota programs DNA methylation to control intestinal homeostasis and inflammation
Ihab Ansari et al.
NATURE MICROBIOLOGY (2020)
Fecal microbiota transplantation to maintain remission in Crohn's disease: a pilot randomized controlled study
Harry Sokol et al.
MICROBIOME (2020)
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor
Raffaella Maria Gadaleta et al.
EBIOMEDICINE (2020)
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells
Clarissa Campbell et al.
NATURE (2020)
Total alkaloids of Sophora alopecuroides L. ameliorated murine colitis by regulating bile acid metabolism and gut microbiota
Ya-qian Jia et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease
Kay Diederen et al.
SCIENTIFIC REPORTS (2020)
Exclusive enteral nutrition in Crohn's disease: Evidence and practicalities
James J. Ashton et al.
CLINICAL NUTRITION (2019)
Emerging roles of bile acids in mucosal immunity and inflammation
Mei Lan Chen et al.
MUCOSAL IMMUNOLOGY (2019)
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases
Jason Lloyd-Price et al.
NATURE (2019)
ILC3 function as a double-edged sword in inflammatory bowel diseases
Boning Zeng et al.
CELL DEATH & DISEASE (2019)
A randomised, double-blind, placebo-controlled trial of a multi-strain probiotic in patients with asymptomatic ulcerative colitis and Crohn's disease
Ingvar Bjarnason et al.
INFLAMMOPHARMACOLOGY (2019)
Systematic assessment of secondary bile acid metabolism in gut microbes reveals distinct metabolic capabilities in inflammatory bowel disease
Almut Heinken et al.
MICROBIOME (2019)
Imbalance of autophagy and apoptosis in intestinal epithelium lacking the vitamin D receptor
Rong Lu et al.
FASEB JOURNAL (2019)
Targeting immune cell circuits and trafficking in inflammatory bowel disease
Markus F. Neurath
NATURE IMMUNOLOGY (2019)
Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease
Yi Jie Weng et al.
JOURNAL OF DIGESTIVE DISEASES (2019)
The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications
Jessica R. Allegretti et al.
LANCET (2019)
Diet-induced remission in chronic enteropathy is associated with altered microbial community structure and synthesis of secondary bile acids
Shuai Wang et al.
MICROBIOME (2019)
Bile acid metabolites control TH17 and Treg cell differentiation
Saiyu Hang et al.
NATURE (2019)
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Zachariah DeFilipp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Specific Bacteria and Metabolites Associated With Response to Fecal Microbiota Transplantation in Patients With Ulcerative Colitis
Sudarshan Paramsothy et al.
GASTROENTEROLOGY (2019)
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice
Graham J. Britton et al.
IMMUNITY (2019)
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis A Randomized Clinical Trial
Samuel P. Costello et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Pharmacological Activation of PXR and CAR Downregulates Distinct Bile Acid-Metabolizing Intestinal Bacteria and Alters Bile Acid Homeostasis
Joseph L. Dempsey et al.
TOXICOLOGICAL SCIENCES (2019)
Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
Talima Pearson et al.
CANCER MEDICINE (2019)
Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome
Ziwei Song et al.
MICROBIOME (2019)
Gut microbiome structure and metabolic activity in inflammatory bowel disease
Eric A. Franzosa et al.
NATURE MICROBIOLOGY (2019)
Engineered E. coli Nissle 1917 for the delivery of matrix-tethered therapeutic domains to the gut
Pichet Praveschotinunt et al.
NATURE COMMUNICATIONS (2019)
Inulin-type fructans improve active ulcerative colitis associated with microbiota changes and increased short-chain fatty acids levels
Rosica Valcheva et al.
GUT MICROBES (2019)
Lactobacillus plantarum CCFM8661 modulates bile acid enterohepatic circulation and increases lead excretion in mice
Qixiao Zhai et al.
FOOD & FUNCTION (2019)
The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status
Mayur Garg et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2019)
Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review
Mahboube Ganji-Arjenaki et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Interactions Between Diet and the Intestinal Microbiota Alter Intestinal Permeability and Colitis Severity in Mice
Sean R. Llewellyn et al.
GASTROENTEROLOGY (2018)
Detection of Gut Dysbiosis due to Reduced Clostridium Subcluster XIVa Using the Fecal or Serum Bile Acid Profile
Masashi Murakami et al.
INFLAMMATORY BOWEL DISEASES (2018)
Primary sclerosing cholangitis
Jessica K. Dyson et al.
LANCET (2018)
Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease
Tawnya Hansen et al.
NUTRIENTS (2018)
Effects of prebiotic inulin-type fructans on blood metabolite and hormone concentrations and faecal microbiota and metabolites in overweight dogs
Celeste Alexander et al.
BRITISH JOURNAL OF NUTRITION (2018)
Bile Acids Activated Receptors Regulate innate immunity
Stefano Fiorucci et al.
FRONTIERS IN IMMUNOLOGY (2018)
Fecal transplantation for treatment of inflammatory bowel disease
Aamer Imdad et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2018)
Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis
Lei He et al.
ENDOCRINOLOGY (2018)
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
R. Balfour Sartor et al.
GASTROENTEROLOGY (2017)
Understanding and Preventing the Global Increase of Inflammatory Bowel Disease
Gilaad G. Kaplan et al.
GASTROENTEROLOGY (2017)
Prebiotic inulin-type fructans induce specific changes in the human gut microbiota
Doris Vandeputte et al.
GUT (2017)
A microbial signature for Crohn's disease
Victoria Pascal et al.
GUT (2017)
OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial
S. Costello et al.
Journal of Crohns & Colitis (2017)
Tauroursodeoxycholic acid protects bile acid homeostasis under inflammatory conditions and dampens Crohn's disease-like ileitis
Lien Van den Bossche et al.
LABORATORY INVESTIGATION (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Interactions between gut bacteria and bile in health and disease
Sarah L. Long et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
PXR: More Than Just a Master Xenobiotic Receptor
Peter O. Oladimeji et al.
MOLECULAR PHARMACOLOGY (2017)
The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics
Glenn R. Gibson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
The Role of Environmental Factors in the Pathogenesis of Inflammatory Bowel Diseases A Review
Dror S. Shouval et al.
JAMA PEDIATRICS (2017)
Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism
Jose A. Caparros-Martin et al.
MICROBIOME (2017)
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
Alexa R. Weingarden et al.
GUT MICROBES (2017)
Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System
Thomas Siegmund Postler et al.
CELL METABOLISM (2017)
Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon
Joseph B. J. Ward et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice
Lien Van den Bossche et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis
Rebecca L. Knoll et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
The Spectrum and Regulatory Landscape of Intestinal Innate Lymphoid Cells Are Shaped by the Microbiome
Meital Gury-BenAri et al.
CELL (2016)
Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome
Chuansheng Guo et al.
IMMUNITY (2016)
Genome-wide association analysis identifies variation in vitamin D receptor and other host factors influencing the gut microbiota
Jun Wang et al.
NATURE GENETICS (2016)
Understanding the mechanisms of faecal microbiota transplantation
Alexander Khoruts et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Fecal Transplants: What Is Being Transferred?
Diana P. Bojanova et al.
PLOS BIOLOGY (2016)
Farnesoid X Receptor Signaling Shapes the Gut Microbiota and Controls Hepatic Lipid Metabolism
Limin Zhang et al.
MSYSTEMS (2016)
A Disease-Associated Microbial and Metabolomics State in Relatives of Pediatric Inflammatory Bowel Disease Patients
Jonathan P. Jacobs et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)
Extensive Modulation of the Fecal Metagenome in Children With Crohn's Disease During Exclusive Enteral Nutrition
Christopher Quince et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function
Caleb J. Kelly et al.
CELL HOST & MICROBE (2015)
Description of health problem
Alexander Tsertsvadze et al.
HEALTH TECHNOLOGY ASSESSMENT (2015)
Interleukin-12 and-23 Control Plasticity of CD127+ Group 1 and Group 3 Innate Lymphoid Cells in the Intestinal Lamina Propria
Jochem H. Bernink et al.
IMMUNITY (2015)
Regulatory immune cells in regulation of intestinal inflammatory response to microbiota
M. Sun et al.
MUCOSAL IMMUNOLOGY (2015)
Bile Acid-Activated Receptors, Intestinal Microbiota, and the Treatment of Metabolic Disorders
Stefano Fiorucci et al.
TRENDS IN MOLECULAR MEDICINE (2015)
The Role of Probiotic Lactic Acid Bacteria and Bifidobacteria in the Prevention and Treatment of Inflammatory Bowel Disease and Other Related Diseases: A Systematic Review of Randomized Human Clinical Trials
Maria Jose Saez-Lara et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Dynamic changes in short- and long-term bacterial composition following fecal microbiota transplantation for recurrent Clostridium difficile infection
Alexa Weingarden et al.
MICROBIOME (2015)
Intestinal epithelial vitamin D receptor deletion leads to defective autophagy in colitis
Shaoping Wu et al.
GUT (2015)
Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results
Bota Cui et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Changes in bile acids, FGF-19 and sterol absorption in response to bile salt hydrolase active L. reuteri NCIMB 30242
Christopher J. Martoni et al.
GUT MICROBES (2015)
The Treatment-Naive Microbiome in New-Onset Crohn's Disease
Dirk Gevers et al.
CELL HOST & MICROBE (2014)
The bile acid TGR5 membrane receptor: From basic research to clinical application
Henri Duboc et al.
DIGESTIVE AND LIVER DISEASE (2014)
Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro
Karen P. Scott et al.
FEMS MICROBIOLOGY ECOLOGY (2014)
Oral Delivery of IL-27 Recombinant Bacteria Attenuates Immune Colitis in Mice
Miranda L. Hanson et al.
GASTROENTEROLOGY (2014)
A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis
Kathleen Machiels et al.
GUT (2014)
Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4
Madhukumar Venkatesh et al.
IMMUNITY (2014)
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
F. M. Ruemmele et al.
JOURNAL OF CROHNS & COLITIS (2014)
Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death
Debby Laukens et al.
LABORATORY INVESTIGATION (2014)
Diet rapidly and reproducibly alters the human gut microbiome
Lawrence A. David et al.
NATURE (2014)
Shaping macrophages function and innate immunity by bile acids: Mechanisms and implication in cholestatic liver diseases
Yvon Calmus et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
Microbiota Modification with Probiotics Induces Hepatic Bile Acid Synthesis via Downregulation of the Fxr-Fgf15 Axis in Mice
Chiara Degirolamo et al.
CELL REPORTS (2014)
Bile Acid Signaling in Metabolic Disease and Drug Therapy
Tiangang Li et al.
PHARMACOLOGICAL REVIEWS (2014)
Metabolism of Cholesterol and Bile Acids by the Gut Microbiota
Philippe Gerard
PATHOGENS (2014)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease
Arnaud Bourreille et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc et al.
GUT (2013)
TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease
Kazuaki Yoneno et al.
IMMUNOLOGY (2013)
Intestinal epithelial vitamin D receptor signaling inhibits experimental colitis
Weicheng Liu et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Bile acids PKA-dependently induce a switch of the IL-10/IL-12 ratio and reduce proinflammatory capability of human macrophages
Katrin Haselow et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Yukihiro Furusawa et al.
NATURE (2013)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li et al.
NATURE COMMUNICATIONS (2013)
Randomised clinical trial: the effectiveness of Lactobacillus reuteri ATCC 55730 rectal enema in children with active distal ulcerative colitis
S. Oliva et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Bile acids induce monocyte differentiation toward interleukin-12 hypo-producing dendritic cells via a TGR5-dependent pathway
Riko Ichikawa et al.
IMMUNOLOGY (2012)
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease
Kirsten Boonstra et al.
INFLAMMATORY BOWEL DISEASES (2012)
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Suzanne Devkota et al.
NATURE (2012)
Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature
Jason K. Hou et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
High-Dose Ursodeoxycholic Acid Is Associated With the Development of Colorectal Neoplasia in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis
John E. Eaton et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
K. B. M. Saiful Islam et al.
GASTROENTEROLOGY (2011)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M. Gadaleta et al.
GUT (2011)
Pregnane X Receptor (PXR/NR1I2) Gene Haplotypes Modulate Susceptibility to Inflammatory Bowel Disease
Juergen Glas et al.
INFLAMMATORY BOWEL DISEASES (2011)
The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis
Sabrina Cipriani et al.
PLOS ONE (2011)
Intestinal steroid profiles and microbiota composition in colitic mice
Steffen Wohlgemuth et al.
GUT MICROBES (2011)
Treatment of Relapsing Mild-to-Moderate Ulcerative Colitis With the Probiotic VSL#3 as Adjunctive to a Standard Pharmaceutical Treatment: A Double-Blind, Randomized, Placebo-Controlled Study
Antonio Tursi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease
Raffaella M. Gadaleta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Probiotics and the gut microbiota in intestinal health and disease
Melanie G. Gareau et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Effect of a Probiotic Preparation (VSL# 3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis
Erasmo Miele et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Bile Salts Control the Antimicrobial Peptide Cathelicidin Through Nuclear Receptors in the Human Biliary Epithelium
Emilie D'Aldebert et al.
GASTROENTEROLOGY (2009)
The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity
Piero Vavassori et al.
JOURNAL OF IMMUNOLOGY (2009)
Sustained modulation of intestinal bacteria by exclusive enteral nutrition used to treat children with Crohn's disease
S. T. Leach et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface
Shipra Vaishnava et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Exploring the full spectrum of macrophage activation
David M. Mosser et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Role of the PXR gene locus in inflammatory bowel diseases
Alfonso Martinez et al.
INFLAMMATORY BOWEL DISEASES (2007)
Human cecal bile acids: concentration and spectrum
James P. Hamilton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Oral oligofructose-enriched inulin supplementation in acute ulcerative colitis is well tolerated and associated with lowered faecal calprotectin
F. Casellas et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-κB target gene expression
Yatrik M. Shah et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Mutual repression between steroid and xenobiotic receptor and NF-κB signaling pathways links xenobiotic metabolism and inflammation
Changcheng Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
M. A. Zocco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
T Inagaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
VSL#3 probiotic mixture - A review of its use in chronic inflammatory bowel diseases
Therese M. Chapman et al.
DRUGS (2006)
The interaction between bacteria and bile
M Begley et al.
FEMS MICROBIOLOGY REVIEWS (2005)
Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice
K Vandenbroucke et al.
GASTROENTEROLOGY (2004)
Loss of detoxification in inflammatory bowel disease: Dysregulation of pregnane X receptor target genes
T Langmann et al.
GASTROENTEROLOGY (2004)
Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis
K Kato et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine
W Kruis et al.
GUT (2004)
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
DS Pardi et al.
GASTROENTEROLOGY (2003)
Vitamin D receptor as an intestinal bile acid sensor
M Makishima et al.
SCIENCE (2002)
Probiotic bacteria enhance murine and human intestinal epithelial barrier function
K Madsen et al.
GASTROENTEROLOGY (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility
JD Simmons et al.
GUT (2000)
Protective effect of the bile salt hydrolase-active Lactobacillus reuteri against bile salt cytotoxicity
P De Boever et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2000)